| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |